News

Candesic provided commercial due diligence to the investors providing $80m of growth capital to pioneering AI drug discovery company CytoReason. CytoReason, which offers life sciences companies AI-enabled drug discovery tools to gather data-driven and molecular-level insights to improve success ...

Read more

Leading mid-market private equity group Duke Street is acquiring mobile rental solutions and pre-owned imaging equipment and spare parts supplier AGITO Medical from Philips. The Candesic team led by Senior Partner Marc Kitten and supervised by Engagement Manager Fabio Ruffinoni and Senior ...

Read more

Nordic Capital is acquiring a majority stake in Sensio, a leading provider in smart monitoring technology for elderly and social care settings. The Candesic team led by Senior Partner Dr Michelle Tempest provided commercial due diligence to Nordic Capital, with Senior Engagement Manager Dr ...

Read more

Leading European private equity firm Exponent is acquiring Northern Ireland’s largest private healthcare provider Kingsbridge Healthcare Group (KHG).The Candesic team, led by Dr Leonid Shapiro, provided operational due diligence to Exponent, with an emphasis on looking at the potential for ...

Read more

A consortium of Swiss Life Asset Managers and Vesper Next Generation Infrastructure Fund I has reached a binding agreement to buy a majority stake in Germany-based diagnostic imaging specialist RAD-x from specialised healthcare investor Gilde Healthcare.Candesic provided commercial due ...

Read more

Candesic is pleased to have assisted HBSUK with vendor commercial due diligence on its acquisition by insurance giant AXA Health on Friday. HBSUK supports public and private healthcare providers in reducing waiting lists and giving rapid access to healthcare professionals, whether ...

Read more

We are pleased to announce that Candesic provided vendor commercial due diligence to Centene Corporation in the context of their sale of Operose Health to HCRG Care Group. Operose Health is a UK leader in delivering exceptional NHS care to hundreds of thousands of patients nationwide ...

Read more

Congratulations to the team at TPG on their majority investment in Outcomes First Group! Candesic provided commercial due diligence to TPG. Outcomes First Group is a leading provider of education and care for children, young people, and adults with special educational needs (SEN) and ...

Read more

Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners. Julius Clinical is a leading academic clinical CRO providing clinical trial services and real-world evidence ...

Read more

Congratulations to NorthEdge on their acquisition of Torbay Pharmaceuticals. Candesic provided commercial due diligence to NorthEdge. Torbay Pharmaceuticals is a fast growing specialist sterile injectable contract manufacturer. The investment will strengthen capabilities and accelerate ...

Read more